Catalent: FY17 expectations exceeded, biologics strategy making strides
Catalent’s financial results have exceeded expectations, says CEO, as the market moves towards “fewer, bigger, better suppliers.”
Archives for August 28, 2017
Dutch CRO Viroclinics acquired by PE firm
Viroclinics Biosciences is expanding its service offering – and eyeing acquisition – following an investment by Parcom Capital.
AZ confirms Macclesfield plan but says “wait to see” Brexit strategy unchanged
AstraZeneca has said it will wait to see how Brexit negotiations progress before deciding whether to make mid-to-large scale manufacturing investments in the UK.
US FDA says Acorda can't file Inbrija NDA and asks for production data
The US FDA has refused to let Acorda Therapeutics Inc. file an NDA for Inbrija, its inhalable version of levodopa.
Interpol led operation seized 420 tonnes of fake meds in West Africa
420 tonnes of counterfeit pharmaceuticals have been seized in West Africa in an operation co-ordinated by Interpol.
US FDA steps up enforcement against unscrupulous stem cell firms
The US FDA has warned a Florida-based clinic and seized vials of a smallpox vaccine in California used to create an unapproved product in a crackdown against "unscrupulous" stem cell firms.
Indian Gov outlines plan to favour drugs containing locally made APIs
Price controls and procurement programmes would favour drugs containing locally-made APIs under a Government proposal designed to reduce India's reliance on imported ingredients and intermediates.
Catalent looking to parenteral dosage form capability for future expansion
Catalent says it will focus its M&A strategy to fill the injectables capability gap in its CDMO offering.